We serve Chemical Name:ethyl 4-hydroxy-6-oxo-2-(trifluoromethyl)-1H-pyridine-3-carboxylate CAS:103900-77-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 4-hydroxy-6-oxo-2-(trifluoromethyl)-1H-pyridine-3-carboxylate
CAS.NO:103900-77-2
Synonyms:ethyl 4,6-dihydroxy-2-(trifluoromethyl)nicotinate;ethyl 4,6-dihydroxy-2-(trifluoromethyl)pyridine-3-carboxylate;4,6-dihydroxy-2-trifluoromethyl-nicotinic acid ethyl ester;ethyldihydroxytrifluoromethylnicotinate;Ethyl 4,6-Dihydroxy-2-(trifluoromethyl)-3-pyridinecarboxylate
Molecular Formula:C9H8F3NO4
Molecular Weight:251.15900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:79.65000
Exact Mass:251.04100
LogP:1.68830
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 4,6-dihydroxy-2-(trifluoromethyl)nicotinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 4,6-Dihydroxy-2-(trifluoromethyl)-3-pyridinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 4,6-dihydroxy-2-(trifluoromethyl)pyridine-3-carboxylate Use and application,4,6-dihydroxy-2-trifluoromethyl-nicotinic acid ethyl ester technical grade,usp/ep/jp grade.
Related News: For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. 5-Quinolinecarboxylic acid, 4-bromo-7-fluoro-2-(trifluoromethyl)- manufacturers The PLI scheme aims to accelerate indigenous manufacturing of critical bulk drugs for which India is dependent on imports. Under this scheme government offered incentives varying between 10 to 20%. 2,4-dimethyl-cyclobutane-1,3-dione dioxime suppliers The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. Tupichinol A vendor & factory.
